1. Home
  2. VTMX vs CGON Comparison

VTMX vs CGON Comparison

Compare VTMX & CGON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTMX
  • CGON
  • Stock Information
  • Founded
  • VTMX 1998
  • CGON 2010
  • Country
  • VTMX Mexico
  • CGON United States
  • Employees
  • VTMX N/A
  • CGON N/A
  • Industry
  • VTMX
  • CGON
  • Sector
  • VTMX
  • CGON
  • Exchange
  • VTMX Nasdaq
  • CGON NYSE
  • Market Cap
  • VTMX 2.3B
  • CGON 2.2B
  • IPO Year
  • VTMX 2023
  • CGON 2024
  • Fundamental
  • Price
  • VTMX $24.28
  • CGON $33.47
  • Analyst Decision
  • VTMX Buy
  • CGON Strong Buy
  • Analyst Count
  • VTMX 2
  • CGON 8
  • Target Price
  • VTMX $35.00
  • CGON $63.88
  • AVG Volume (30 Days)
  • VTMX 156.8K
  • CGON 443.7K
  • Earning Date
  • VTMX 10-24-2024
  • CGON 11-12-2024
  • Dividend Yield
  • VTMX 2.97%
  • CGON N/A
  • EPS Growth
  • VTMX 2.33
  • CGON N/A
  • EPS
  • VTMX 0.39
  • CGON N/A
  • Revenue
  • VTMX $243,239,612.00
  • CGON $684,000.00
  • Revenue This Year
  • VTMX N/A
  • CGON $411.76
  • Revenue Next Year
  • VTMX $21.87
  • CGON $405.27
  • P/E Ratio
  • VTMX $5.96
  • CGON N/A
  • Revenue Growth
  • VTMX 18.11
  • CGON 258.12
  • 52 Week Low
  • VTMX $23.77
  • CGON $25.77
  • 52 Week High
  • VTMX $41.44
  • CGON $50.23
  • Technical
  • Relative Strength Index (RSI)
  • VTMX 36.14
  • CGON 40.88
  • Support Level
  • VTMX $24.98
  • CGON $31.28
  • Resistance Level
  • VTMX $25.99
  • CGON $40.47
  • Average True Range (ATR)
  • VTMX 1.05
  • CGON 1.91
  • MACD
  • VTMX -0.07
  • CGON -0.51
  • Stochastic Oscillator
  • VTMX 8.53
  • CGON 23.83

About VTMX Corporacion Inmobiliaria Vesta S.A.B de C.V. each representing ten (10)

Corporacion Inmobiliaria Vesta SAB de CV is a real estate company dedicated to the development and leasing of industrial buildings and distribution centers in Mexico. The Company's primary business is the acquisition, development, and management of industrial and distribution center real estate. The company designs and constructs park-to-suit projects across various industries; undertakes build-to-suit projects; and provides site selection, design and engineering, and sale and leaseback services. The primary source of revenues is the rental income received from customers under operating leases. It serves aerospace, automotive, food and beverage, logistics, medical devices, plastics, and other industries.

About CGON CG ONCOLOGY INC

CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.

Share on Social Networks: